You are here

Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Vienna, , A-1090 Austria
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Neuropathic Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Neuropathic pain of peripheral origin demonstrating spontaneous ongoing pain and
dynamic mechanical allodynia to brush stimuli.

- A present pain intensity score of 4 or more (out of 10) for spontaneous ongoing pain
and brush-evoked allodynia at the skin area at screen.

- Stable analgesic medication (excluding pregabalin) for a minimum of 1 month prior to
the start of study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who have undergone neurolytic or neurosurgical therapy.

- Patients who have trigeminal neuralgia, central pain (due to cerebrovascular lesions,
multiple sclerosis and traumatic spinal cord injuries), complex regional pain syndrome
(Type I and II), and phantom limb pain.

- Patients who have previously been treated with pregabalin.

NCT01117766
Pfizer
Completed
Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Central Neuropathic Pain
NCT00313820
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now